Therapeutic effect of SDDS (2-sulfamoyl-4, 4'-diaminodiphenyl sulfone) on experimental toxoplasmosis.
D000818:Animals; D051379:Mice; D012698:Serologic Tests; D013450:Sulfones / Q000627:therapeutic use*; D013552:Swine; D014122:Toxoplasma / Q000302:isolation & purification; D014124:Toxoplasmosis, Animal / Q000188:drug therapy* / Q000276:immunology
D013450:Sulfones